Form 8-K - Current report:
SEC Accession No. 0001178913-23-003664
Filing Date
2023-11-14
Accepted
2023-11-14 07:30:21
Documents
15
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2330537.htm   iXBRL 8-K 33716
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 96738
7 image0.jpg GRAPHIC 4528
  Complete submission text file 0001178913-23-003664.txt   335170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20231114.xsd EX-101.SCH 4676
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20231114_def.xml EX-101.DEF 18390
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20231114_lab.xml EX-101.LAB 28709
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20231114_pre.xml EX-101.PRE 20632
9 EXTRACTED XBRL INSTANCE DOCUMENT zk2330537_htm.xml XML 6879
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 231401587
SIC: 2836 Biological Products, (No Diagnostic Substances)